This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Eli A Stahl: Innovator in Immunology
Introduction
Eli A Stahl is a prominent inventor based in Tarrytown, NY (US). He has made significant contributions to the field of immunology, holding 3 patents that focus on innovative treatments for immune disorders.
Latest Patents
Stahl's latest patents include groundbreaking methods for treating MHC-I-opathy risk haplotypes. This patent provides methods of treating subjects with immune disorders by administering a therapeutically effective amount of an Endoplasmic Reticulum Aminopeptidase 2 (ERAP2) inhibitor in combination with an HLA-A29 or HLA-B27 inhibitory nucleic acid molecule. Another notable patent addresses the treatment of uveitis using ERAP1 inhibitors, offering methods for treating subjects with uveitis and identifying those at increased risk of developing the condition.
Career Highlights
Eli A Stahl is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance research in immunology. His work has been instrumental in developing therapies that target complex immune responses.
Collaborations
Stahl collaborates with talented colleagues, including Sahar Gelfman and Ann Ligocki, to further enhance the impact of their research in the field.
Conclusion
Eli A Stahl's innovative work in immunology exemplifies the importance of research and development in treating immune disorders. His contributions through patents and collaboration with fellow researchers continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile